Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Potkin, S. G. Articles by Gulasekaram, B. Search for Related Content PubMed Citation Articles by Potkin, S. G. Articles by Gulasekaram, B. Schizophrenia Spectrum Disorders Other Neuroleptics

Effect of Clozapine and Adjunctive High-Dose Glycine in Treatment-Resistant Schizophrenia

OBJECTIVE: The focus of this study was the systematic evaluation of the clinical effects of glycine as an adjunct to the atypical antipsychotic clozapine in the treatment of schizophrenia. METHOD: In a double-blind, placebo-controlled study, 19 patients with chronic, treatment-resistant schizophrenia who were maintained on optimal doses of clozapine (400–1200 mg/day) were administered either 30 g/day of glycine (N=9) or placebo (N=10) for 12 weeks. Clinical evaluations with the Brief Psychiatric Rating Scale, the Scale for the Assessment of Negative Symptoms, and the Simpson-Angus movement scale were completed biweekly. RESULTS: The use of glycine as an adjunct to clozapine was not effective in decreasing positive or negative symptoms. In contrast, the patients treated with clozapine without glycine had a 35% reduction in positive symptoms. CONCLUSIONS: These preliminary data suggest that glycine may interfere with the antipsychotic efficacy of atypical neuroleptics such as clozapine.

This article has been cited by other articles:

				B. Chavez and R. A Poveda Efficacy with High-Dose Aripiprazole After Olanzapine-Related Metabolic Disturbances Ann. Pharmacother., December 1, 2006; 40(12): 2265 - 2268. [Abstract] [Full Text] [PDF]

				D. C. Goff and J. T. Coyle The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia Am J Psychiatry, September 1, 2001; 158(9): 1367 - 1377. [Abstract] [Full Text] [PDF]

				A. E. Evins, S. M. Fitzgerald, L. Wine, R. Rosselli, and D. C. Goff Placebo-Controlled Trial of Glycine Added to Clozapine in Schizophrenia Am J Psychiatry, May 1, 2000; 157(5): 826 - 828. [Abstract] [Full Text]

				G. E. Tsai, P. Yang, L.-C. Chung, I-C. Tsai, C.-W. Tsai, and J. T. Coyle D-Serine Added to Clozapine for the Treatment of Schizophrenia Am J Psychiatry, November 1, 1999; 156(11): 1822 - 1825. [Abstract] [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us